ASMB Assembly Biosciences, Inc.
$29.80▼ -2.17%
Healthcare
Other
After hours
$29.80▲ +0.00%
Sep 11, 7:30 PM ET
Volume 258.9K
Avg Volume (10D) 292.9K
Key Metrics & Fundamentals
Market Cap
$606.75M
P/E Ratio
24.0
Div Yield
–%
52W Range
20.23 - 39.71
% vs 50 MA
0.70%
% vs 200 MA
2.04%
RSI-14
41.5
MACD Histogram
-0.7800
Beta (1Y vs SPY)
1.31
Free Cash Flow
-$15.49M
Gross Rev
$13.37M
Gross Profit
$13.37M
EBITDA
-$6.32M
COGS
–
Operating Exp
$19.72M
Operating Income
-$6.34M
EBIT
-$6.34M
Pretax Income
-$3.86M
Net Income
-$3.86M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 8:15 PM
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
Zacks · Sep 9, 2026 12:41 PM
Assembly Biosciences Exercises Option to Share US Costs, Profits for Herpes Program With Gilead
MT Newswires · Sep 8, 2026 9:14 PM
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
GlobeNewswire · Sep 8, 2026 8:00 PM
Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services
Zacks · Sep 8, 2026 1:48 PM
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High?
Zacks · Sep 7, 2026 1:55 PM
Should You Buy Assembly Biosciences (ASMB) After Golden Cross?
Zacks · Sep 4, 2026 1:55 PM
5 Stocks With Recent Price Strength Buoyed by a Strong August
Zacks · Sep 4, 2026 12:56 PM
Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going
Zacks · Sep 3, 2026 12:55 PM
Best Momentum Stocks to Buy for August 25th
Zacks · Aug 25, 2026 2:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ASMB's money flow as a full page
Social Sentiment
No Reddit posts found for ASMB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.